Spark Investment Management LLC Has $1,390,000 Position in Chemed Corp. (CHE)
Spark Investment Management LLC held its stake in Chemed Corp. (NYSE:CHE) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,800 shares of the company’s stock at the end of the second quarter. Spark Investment Management LLC’s holdings in Chemed Corp. were worth $1,390,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of CHE. Citadel Advisors LLC increased its position in shares of Chemed Corp. by 195.4% in the first quarter. Citadel Advisors LLC now owns 4,558 shares of the company’s stock worth $833,000 after buying an additional 3,015 shares during the last quarter. Ronald Blue & Co. LLC increased its position in shares of Chemed Corp. by 2.2% in the first quarter. Ronald Blue & Co. LLC now owns 2,690 shares of the company’s stock worth $491,000 after buying an additional 58 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Chemed Corp. by 7.5% in the first quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock worth $328,070,000 after buying an additional 125,018 shares during the last quarter. Glen Harbor Capital Management LLC increased its position in shares of Chemed Corp. by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 624 shares of the company’s stock worth $114,000 after buying an additional 64 shares during the last quarter. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of Chemed Corp. by 94.5% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 3,186 shares of the company’s stock worth $582,000 after buying an additional 1,548 shares during the last quarter. Institutional investors own 98.33% of the company’s stock.
Shares of Chemed Corp. (CHE) opened at 198.79 on Wednesday. The stock has a market capitalization of $3.18 billion, a price-to-earnings ratio of 49.32 and a beta of 1.14. The stock’s 50 day moving average is $203.00 and its 200 day moving average is $190.92. Chemed Corp. has a 1-year low of $130.05 and a 1-year high of $216.01.
Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.26. The firm had revenue of $415.06 million for the quarter, compared to the consensus estimate of $407.56 million. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.80 earnings per share. On average, equities analysts forecast that Chemed Corp. will post $8.20 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 1st. Investors of record on Monday, August 14th will be issued a dividend of $0.28 per share. The ex-dividend date of this dividend is Thursday, August 10th. This represents a $1.12 dividend on an annualized basis and a yield of 0.56%. This is an increase from Chemed Corp.’s previous quarterly dividend of $0.26. Chemed Corp.’s payout ratio is currently 26.07%.
WARNING: “Spark Investment Management LLC Has $1,390,000 Position in Chemed Corp. (CHE)” was first posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.dailypolitical.com/2017/08/09/spark-investment-management-llc-has-1390000-position-in-chemed-corp-che.html.
Several equities analysts recently issued reports on the company. Zacks Investment Research raised Chemed Corp. from a “hold” rating to a “buy” rating and set a $226.00 target price on the stock in a research report on Friday, July 28th. BidaskClub downgraded Chemed Corp. from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 22nd. TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $208.00 price target on shares of Chemed Corp. in a report on Wednesday, July 5th. Finally, Oppenheimer Holdings, Inc. upped their price target on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, July 27th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $218.33.
In other Chemed Corp. news, Director George J. Walsh III purchased 1,000 shares of Chemed Corp. stock in a transaction on Monday, June 26th. The shares were bought at an average price of $204.56 per share, with a total value of $204,560.00. Following the completion of the acquisition, the director now directly owns 7,908 shares of the company’s stock, valued at $1,617,660.48. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Kevin J. Mcnamara sold 15,000 shares of the company’s stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $201.16, for a total transaction of $3,017,400.00. Following the completion of the sale, the insider now directly owns 173,801 shares in the company, valued at approximately $34,961,809.16. The disclosure for this sale can be found here. 5.32% of the stock is currently owned by insiders.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.